Vision By Design 2026

October 21, 2026 to October 24, 2026

Vision by Design is an annual conference where the global myopia community gathers to learn, connect, and shape the future of care. Four intensive days of clinical education, emerging research, and real-world strategy.

Target Audience

This educational activity is designed for optometrists and ophthalmologists who wish to expand their knowledge and clinical competence in myopia management. The program is appropriate for eye care professionals who are new to myopia management as well as practitioners seeking to enhance their understanding of current evidence-based treatment strategies.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the epidemiology and public health impact of childhood myopia and progressive myopia.
  • Identify patients at risk for developing or progressing myopia through appropriate clinical evaluation and risk assessment.
  • Compare current evidence-based myopia management treatment options, including: Orthokeratology Soft multifocal/myopia control contact lenses Low-dose atropine therapy Combination treatment approaches Explain treatment selection criteria, implementation protocols, and monitoring strategies for each modality.
  • Discuss practical approaches for incorporating myopia management services into clinical practice.

Commercial Support 
There is no commercial support for this activity.

Course summary

Course opens: 
10/21/2026
Course expires: 
10/24/2026
Event starts: 
10/21/2026 - 7:00am EDT
Event ends: 
10/24/2026 - 11:59pm EDT
Cost:
$0.00
Rating: 
0
Cleveland Convention Center
Cleveland, OH 44113
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Speaker, Instructor, Faculty(s)

Thomas Aller, OD, FBCLA

has a financial relationship (Advisor) with Zeiss;.
has a financial relationship (Consultant) with Euclid Vision;.
has a financial relationship (Consultant) with BHVI;.
has a financial relationship (Individual stocks and stock options) with TreeHouse Eyes;.
has a financial relationship (Royalties or patent beneficiary) with Myopia Care (Eyetific);.
has a financial relationship (Royalties or patent beneficiary) with BHVI;.
has a financial relationship (Advisor) with Reopia Optics, Inc;.
has a financial relationship (Individual stocks and stock options) with Reopia Optics, Inc.;.

Dwight Barnes, O.D., FIAOMC, IAMCC

has no relevant financial relationships to disclose at this time.

Sara Bonds, OD, IACMM

has a financial relationship (Speaker) with Oculus;.

Kevin Cassar, OD

has no relevant financial relationships to disclose at this time.

Zhi Chen

has no relevant financial relationships to disclose at this time.

Nick Despotidis, OD, FAAO, FOVDR, FIAOMC

has no relevant financial relationships to disclose at this time.

Rob Gerowitz, OD, FIAOMC, FSLS, FBCLA

has no relevant financial relationships to disclose at this time.

Randall Kojima

has a financial relationship (Employee) with KATT Design Group;.

Jagrut Lallu, MSc Specialty Lenses (Hons), BOptom (Hons)

has no relevant financial relationships to disclose at this time.

Paul Levine, OD, FIAOMC, FAAO, IACMM

has no relevant financial relationships to disclose at this time.

xinjie mao

has no relevant financial relationships to disclose at this time.

MATTHEW MARTIN, OD IACMM, FIAOMC

has no relevant financial relationships to disclose at this time.

Langis Michaud, OD MS

has a financial relationship (Consultant) with Johnson and Johnson;.
has a financial relationship (Consultant) with Essilor;.
has a financial relationship (Researcher) with Bausch and Lomb;.

Jay Neitz, PhD

has a financial relationship (Royalties or patent beneficiary) with SightGlass Vision;.

Lisa Ostrin

has a financial relationship (Researcher) with Meta, LLC;.
has a financial relationship (Consultant) with Zeiss Medical;.

Jennifer Qayum, OD

has no relevant financial relationships to disclose at this time.

Patrick Simard, OD, MSc, MBA, FAAO, Dipl AAO, FBCLA, FIACLE, FIAOMC, IACMM

has a financial relationship (Researcher) with EssilorLuxottica;.
has a financial relationship (Researcher) with Zilia;.
has a financial relationship (Researcher) with Contamac;.
has a financial relationship (Researcher) with Labtician;.
has a financial relationship (Speaker) with Oculus;.
has a financial relationship (Speaker) with Eaglett Eye;.
has a financial relationship (Consultant) with Nordic Pharma;.
has a financial relationship (Consultant) with Sun Pharma;.
has a financial relationship (Speaker) with Wave Contact Lenses ;.
has a financial relationship (Royalties or patent beneficiary) with Bausch and Lomb;.

Jonathan Skoner, OD, FIAOMC, IACMM

has a financial relationship (Consultant) with Bausch and Lomb;.

Stephanie Tsang, OD, FIAOMC

has no relevant financial relationships to disclose at this time.

Sherman Tung

has a financial relationship (Speaker) with Hoya;.
has a financial relationship (Speaker) with 3N ;.
has a financial relationship (Speaker) with Topcon;.

Tze Yu Tung, OD

has a financial relationship (Executive role) with Shinyeyes Corp;.

Christina Twardowski, OD, FAAO

has no relevant financial relationships to disclose at this time.

Jeffrey Walline, OD PhD

has no relevant financial relationships to disclose at this time.

Thomas Weshefsky, OD, FIAOMC

has no relevant financial relationships to disclose at this time.

jody Wiechmann, Ph.D., FARVO

has no relevant financial relationships to disclose at this time.

Laurence Wong, OD

has no relevant financial relationships to disclose at this time.

Oliver Woo

has a financial relationship (Speaker) with CopperVision Greater China;.
has a financial relationship (Speaker) with SEED JAPAN;.
has a financial relationship (Speaker) with EssilorLuxottica Australia;.
has a financial relationship (Speaker) with EssilorLuxottica Australia;.
has a financial relationship (Speaker) with CopperVision Greater China;.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and The American Academy of Orthokeratology & Myopia Control. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


This activity was planned by and for the healthcare team, and learners will receive XX Interprofessional Continuing Education (IPCE) credit for learning and change.

Price

Cost:
$0.00
Please login or register to take this course.